Ferroptosis role in complexity of cell death: unrevealing mechanisms in Parkinson's disease and therapeutic approaches
- PMID: 39998712
- DOI: 10.1007/s10787-025-01672-7
Ferroptosis role in complexity of cell death: unrevealing mechanisms in Parkinson's disease and therapeutic approaches
Abstract
Parkinson's disease (PD), a common neurodegenerative disorder, is characterized by progressive loss of dopaminergic neurons, and accumulation of α-synuclein in the substantial nigra. Emerging evidence identifies ferroptosis as a regulated iron-dependent cell death mechanism marked by excessive lipid peroxidation (LPO) as a key contributor to PD pathogenesis. Ferroptosis is intertwined with critical disease processes such as aggregation of α-synuclein protein, oxidative stress generation, mitochondrial alteration, iron homeostasis dysregulation, and neuroinflammation. This mechanism disrupts cellular homeostasis by impairing iron metabolism and antioxidant pathways like the xc-/glutathione/GPX4 axis and the CoQ10 pathway. This review consolidates current advancements in understanding ferroptosis in these mechanisms, increasing interest in contribution to PD pathology. In addition, it explores the latest developments in ferroptosis-targeting pharmacological agents, including their application in the preclinical and clinical study, and highlights their potential to revolutionize PD management. Unraveling the interplay between ferroptosis and PD offers a transformative perspective, paving the way for innovative therapies to combat this debilitating disease condition.
Keywords: Fenton reaction; Ferroptosis; Iron dysregulation; Lipid peroxidation (LPO); Neuroinflammation; Parkinson’s disease (PD); α-Synuclein.
© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Ethical approval: Not applicable. Consent to publication: Not applicable. Conflicts of interest: All authors declared the absence of any financial or personal conflicts about this work.
Similar articles
-
Targeting Ferroptosis in Parkinson's Disease: Mechanisms and Emerging Therapeutic Strategies.Int J Mol Sci. 2024 Dec 4;25(23):13042. doi: 10.3390/ijms252313042. Int J Mol Sci. 2024. PMID: 39684753 Free PMC article. Review.
-
Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.Prog Neurobiol. 2021 Jan;196:101890. doi: 10.1016/j.pneurobio.2020.101890. Epub 2020 Jul 26. Prog Neurobiol. 2021. PMID: 32726602 Review.
-
Targeting mitochondria-regulated ferroptosis: A new frontier in Parkinson's disease therapy.Neuropharmacology. 2025 Aug 15;274:110439. doi: 10.1016/j.neuropharm.2025.110439. Epub 2025 Mar 31. Neuropharmacology. 2025. PMID: 40174689 Review.
-
Neuroprotective role of CHCHD2 in Parkinson's disease: Insights into the GPX4-related ferroptosis pathway.Free Radic Biol Med. 2025 Jan;226:348-363. doi: 10.1016/j.freeradbiomed.2024.11.034. Epub 2024 Nov 19. Free Radic Biol Med. 2025. PMID: 39566750
-
Betulinic acid protects against lipopolysaccharide and ferrous sulfate-induced oxidative stress, ferroptosis, apoptosis, and neuroinflammation signaling relevant to Parkinson's Disease.Free Radic Biol Med. 2025 Jun;233:340-354. doi: 10.1016/j.freeradbiomed.2025.04.013. Epub 2025 Apr 7. Free Radic Biol Med. 2025. PMID: 40203997
Cited by
-
The interplay between α-synuclein aggregation and necroptosis in Parkinson's disease: a spatiotemporal perspective.Front Neurosci. 2025 Apr 8;19:1567445. doi: 10.3389/fnins.2025.1567445. eCollection 2025. Front Neurosci. 2025. PMID: 40264913 Free PMC article. Review.
References
-
- Abbaspour N, Hurrell R, Kelishadi R (2014) Review on iron and its importance for human health. J Res Med Sci 19(2):164–174. PMID: 24778671; PMCID: PMC3999603
-
- Alexander GE (2004) Biology of Parkinson’s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 6(3):259–280. https://doi.org/10.31887/DCNS.2004.6.3/galexander
-
- Angelova PR, Horrocks MH, Klenerman D, Gandhi S, Abramov AY, Shchepinov MS (2015) Lipid peroxidation is essential for α-synuclein-induced cell death. J Neurochem 133(4):582–589. https://doi.org/10.1111/jnc.13024 - DOI - PubMed - PMC
-
- Avcı B, Günaydın C, Güvenç T, Yavuz CK, Kuruca N, Bilge SS (2021) Idebenone ameliorates rotenone-induced Parkinson’s disease in rats through decreasing lipid peroxidation. Neurochem Res 46(3):513–522. https://doi.org/10.1007/s11064-020-03186-w - DOI - PubMed
-
- Ayton S, Lei P, Mclean C, Bush AI, Finkelstein DI (2016) Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra. Signal Transduct Target Ther 1:16015. https://doi.org/10.1038/sigtrans.2016.15 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical